- Solid Tumors
- Pipeline Molecules
- Alliance Partners
Our mission is to provide healthcare professionals with unbiased clinical research information, easily.
Currently, you can access the following clinical trials being conducted worldwide:
Clinicaltrials.gov identifier NCT03941353
Recruitment Status Enrolling by invitation
First Posted May 7, 2019
Last update posted July 21, 2020
The aim of this project is to build an international community of centers of excellence in the care for Fragile Hip Fracture Rapid Recovery patients. These centers of excellence will benchmark and share their expertise and experiences based on clinical and managerial data. In project is designed in five different phase: Phase 1: literature review: identifying relevant key interventions and indicators Phase 2: expert panel: expert panel for teams, management and policy makers Phase 3: data collection: collection managerial data through retrospective patient record analysis on clinical indicators Phase 4: statistical data analysis: data input, validation and statistical analysis Phase 5: feedback and knowledge sharing: feedback report with anonymous benchmarking and knowledge sharing of the results.
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, , Learn About Clinical Studies.-->
- Trauma related non-elective admission for hip fracture;
- Minimum age of 65 years;
- The following hip fractures are included: Femoral neck, femoral head, trochanteric and
- Discharged or deceased before May 30th of 2019
- Hip fracture is not the main reason for admission to emergency room;
- Additional ipsilateral fractures;
- Hip fracture resulting from in-hospital fall that occurred in the hospital where the
patient receives hip fracture care.
European Pathway Association